Reading Recurrence Risk from Breast Cancer Slides: Agendia Announces AI Model Validation with Ten-Year Follow-Up
An investigational digital pathology model aims to estimate risk information from a 70-gene test using routinely stained slides. Long-term data show that it can distinguish prognostic groups, but evidence gaps remain before it could replace genomic testing or guide treatment decisions.